Management of Inadequate Methylphenidate Response in Children with ADHD

Dose Optimization Strategy

For a child still experiencing difficulty focusing on methylphenidate, the American Academy of Child and Adolescent Psychiatry recommends increasing the dose to 15-20mg daily, either by increasing the morning dose or adding a second dose at lunchtime 1, 2
The American Academy of Child and Adolescent Psychiatry suggests starting by increasing the morning dose to 15mg for one week, then assessing response before considering further increases 2
Weekly increments of 5-10mg are appropriate for methylphenidate titration until optimal symptom control is achieved, according to the American Academy of Child and Adolescent Psychiatry 2, 3
The maximum daily dose for a child should generally not exceed 60mg total daily dose, as recommended by the American Academy of Child and Adolescent Psychiatry 3

If multiple daily dosing becomes necessary, switching to an extended-release formulation may be beneficial, as suggested by the American Academy of Child and Adolescent Psychiatry 4, 5
Extended-release options, such as OROS-methylphenidate (Concerta), provide up to 12 hours of coverage with a single morning dose, according to the American Academy of Child and Adolescent Psychiatry 5
Extended-release formulations eliminate the need for in-school dosing and reduce the risk of stigmatization, as noted by the American Academy of Child and Adolescent Psychiatry 5

The American Academy of Child and Adolescent Psychiatry recommends using standardized rating scales from both parents and teachers to assess response to dose changes 3, 7
Common side effects to monitor with each dose increase include decreased appetite, sleep disturbances, increased blood pressure and heart rate, and headaches, as reported by the American Academy of Child and Adolescent Psychiatry and Pharmacology and Therapeutics 1, 8
Weighing the patient at each visit to monitor for potential weight loss is also recommended by the American Academy of Child and Adolescent Psychiatry 8

If optimal dosing of methylphenidate fails to provide adequate symptom control, consider switching to lisdexamfetamine or another amphetamine formulation, or trying a non-stimulant medication such as atomoxetine, clonidine, or guanfacine as second-line therapy, as suggested by Pharmacology and Therapeutics 1

Maintaining an inadequate dose when symptoms persist is a common pitfall, as the current dose may be at the lower end of the therapeutic range, according to the American Academy of Child and Adolescent Psychiatry 2
Failure to consider the duration of action and not addressing timing of doses relative to academic demands are also common pitfalls, as noted by the American Academy of Child and Adolescent Psychiatry 6
Overlooking the need for systematic monitoring of both therapeutic effects and side effects is another common pitfall, as reported by the American Academy of Child and Adolescent Psychiatry 2, 3
Prematurely switching medication classes before optimizing the current regimen is also a common pitfall, as cautioned by Pharmacology and Therapeutics 1